We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Neighbor Cell Signals Cause Function Change in Response

By LabMedica International staff writers
Posted on 14 Jan 2019
Print article
Image: Flexible cells: Ordinary cells are not static and predetermined, as was earlier believed. They can change identity and function. This discovery may provide an approach for new types of treatments in the future (Photo courtesy of Dr. Luiza Ghila, University of Bergen).
Image: Flexible cells: Ordinary cells are not static and predetermined, as was earlier believed. They can change identity and function. This discovery may provide an approach for new types of treatments in the future (Photo courtesy of Dr. Luiza Ghila, University of Bergen).
A molecular mechanism has been identified that maintains cell identity via an active process, which is mediated by repressive signals released by neighboring cells that curb an intrinsic trend of differentiated cells to change.

Investigators at the University of Bergen (Norway) and their collaborators were working with a mouse diabetes model as part of their study of the forces that restrict regeneration and maintain cell identity following injury. In the diabetes model, following beta-cell loss, 1–2% of the glucagon-producing alpha-cells spontaneously began producing insulin. Normally, in the pancreas alpha-cells produce glucagon, and this increases blood sugar levels. Beta-cells produce insulin, which decreases glucagon levels while delta-cells produce somatostatin, which controls the regulation of the alpha and beta cells.

The investigators reported in the October 22, 2018, issue of the journal Nature Cell Biology that adaptive alpha-cell identity changes were blocked by intra-islet insulin- and Smoothened-mediated signaling, among others. Smoothened is a Class Frizzled (Class F) G protein-coupled receptor that is a component of the hedgehog signaling pathway.

The combination of beta-cell loss or insulin-signaling inhibition together with Smoothened inactivation in alpha- or delta-cells stimulated insulin production in a greater number of alpha-cells. Thus, the maintenance of cell identity was seen to be an active process mediated by repressive signals, which were released by neighboring cells and curbed an intrinsic trend of differentiated cells to change.

"We are possibly facing the start of a totally new form of treatment for diabetes, where the body can produce its own insulin, with some start-up help," said contributing author Dr. Luiza Ghila, a researcher in the department of clinical science at the University of Bergen. "If we gain more knowledge about the mechanisms behind this cell flexibility, then we could possibly be able to control the process and change more cells' identities so that more insulin can be produced. Furthermore, the cells' ability to change identity and function may be a decisive discovery in treating other diseases caused by cell death, such as Alzheimer´s disease and cellular damage due to heart attacks."

Related Links:
University of Bergen

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
New
Cytomegalovirus Test
NovaLisa Cytomegalovirus (CMV) IgG Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.